Ticker Scorecard - OLMA Basics Company: Olema Pharmaceuticals, Inc. IPO Date: November 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $370.48M Activated in VL: True Average Daily Range Avg Daily Range: $0.55 | 3.98% Avg Daily Range (30 D): $0.23 | 4.06% Avg Daily Range (90 D): $0.31 | 3.89% Institutional Daily Volume Avg Daily Volume: .4M Avg Daily Volume (30 D): .99M Avg Daily Volume (90 D): .76M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 101 Avg Trade Size (Sh.) (90 D): 94 Institutional Trades Total Inst.Trades: 695 Avg Inst. Trade: $1.71M Avg Inst. Trade (30 D): $.94M Avg Inst. Trade (90 D): $.98M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.12M Avg Closing Trade (30 D): $.66M Avg Closing Trade (90 D): $.78M Avg Closing Volume: 156.49K     News Jan 3, 2025 @ 9:30 PM Olema Oncology Reports Inducement Grants Under Nas... Source: N/A Jan 2, 2025 @ 12:00 PM Olema Oncology to Present at 43rd Annual J.P. Morg... Source: N/A Dec 10, 2024 @ 12:00 PM Olema Oncology Presents Updated Clinical Results f... Source: Olema Oncology Sep 4, 2024 @ 8:49 PM Olema Oncology Reports Inducement Grants Under Nas... Source: N/A Aug 21, 2024 @ 11:00 AM Olema Oncology to Participate in Morgan Stanley 22... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.28 $-.6 $-.54 Diluted EPS $-2.28 $-.6 $-.54 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -122.68M $ -34.56M $ -30.38M Operating Income / Loss $ -135.91M $ -37.62M $ -33.53M Cost of Revenue $ $ $ Net Cash Flow $ -81.52M $ 19M $ -16.83M PE Ratio